Eurofins Technologies Launches Wastewater Diagnostic Kit for SARS-CoV-2 Testing Including Identification of Omicron Variant
02 Décembre 2021 - 9:00AM
Business Wire
Eurofins Technologies announces the launch of the VIRSeek
SARS-CoV-2 Mplex I and Mplex II Wastewater real-time RT-PCR kits to
provide an efficient solution for SARS-CoV-2 detection in
wastewater, including the Omicron variant of concern.
Wastewater-based epidemiology has become an important approach
in order to comprehensively monitor the profile of SARS-CoV-2
infections in highly populated areas. Methods to detect SARS-CoV-2
viral RNA in untreated wastewater have advanced over the last
number of months. Data has shown that concentrations of viral RNA
correlate with trends in reported COVID-19 cases, demonstrating the
importance of wastewater testing as a public health tool.
The European Commission has recommended1 the implementation of
effective systems for the surveillance of SARS-CoV-2 in wastewater.
The VIRSeek SARS-CoV-2 Mplex I and Mplex II Wastewater real-time
RT-PCR kits delivers an effective solution for SARS-CoV-2 detection
in wastewater. The VIRSeek SARS-CoV-2 Wastewater kits detects genes
to specifically identify SARS-CoV-2 together with primer/probes
sets to evaluate process parameters such as the nucleic acid
extraction efficiency, a specific water quality indicator or the
impact of matrix inhibition via an internal positive control. The
solution is intended to be used by analytical laboratories for
SARS-CoV-2 analysis in wastewater samples as part of quality
control/quality assurance testing.
These new members of the VIRSeek real-time RT-PCR kit-family for
SARS-CoV-2 detection enhance Eurofins Technologies’ VIRSeek
SARS-CoV-2 Solution offering by also enabling the detection of
mutant variants such as the Omicron variant of concern. The VIRSeek
real-time RT-PCR kit-family also incorporates viral concentration
workflow and subsequent lysis and isolation of the viral SARS-CoV-2
RNA, using the VIRSeek RNAExtractor AE1 kit for automated
platforms.
More information on Eurofins Technologies website.
About Eurofins Technologies – a fast growing provider of
diagnostic technologies in the field of immunoassays and molecular
detection methods
Building on the experience and scientific excellence of the
Eurofins Group, Eurofins Technologies is a fast growing global
provider of diagnostic technologies and industry-leading
ELISA-based instruments in the field of bioanalytical testing for
the food, feed, environmental, animal health, and clinical
diagnostics industries.
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With 55,000 staff across a network
of 900 laboratories in over 50 countries, Eurofins’ companies offer
a portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
1 https://eur-lex.europa.eu/eli/reco/2021/472/oj
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211202005084/en/
Dr. Nadine G�hring ir@eurofins.com
Eurofins Scientific (EU:ERF)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Eurofins Scientific (EU:ERF)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024
